Sofwave Medical Ltd.

As of June 30, 2026, SOFWAVE MED LTD. carries a market capitalization of 577.61M, placing it among publicly traded companies globally. Its enterprise value stands at 550.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, SOFWAVE MED LTD. has 36.10M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, SOFWAVE MED LTD. maintains a current ratio of 2.46, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, SOFWAVE MED LTD. recorded 43,000.00 in income tax expense.

As of the close on October 7, 2026, SOFWAVE MED LTD.'s stock has gained approximately 40.85% over the past 52 weeks.

As of June 30, 2026, SOFWAVE MED LTD. holds 28.31M in cash and equivalents against 1.43M in total debt, resulting in a net debt position of -28.24M. Total book value stands at 38.02M, with working capital of 33.89M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.